GBCHealth is delighted to welcome six new members from the corporate and non-profit sectors. Each will bring new ideas, expertise and energy to the GBCHealth network. Welcome!
Cameron International is a Fortune 500 company providing equipment, systems and services to worldwide oil, gas and process industries.
JDRF is a global organization focused on type 1 diabetes research for better treatments and a cure.
Jhpiego is an international non-profit health organization that designs innovative, effective and low-cost health care solutions to ensure a high level of care for women and their families.
Kenya Healthcare Federation (KHF) is dedicated to engaging the government and stakeholders in achieving quality healthcare by enabling policies that maximize the contribution of the private sector.
MosquitoZone offers programs for malaria and other vector-borne diseases to companies in the energy, mining and construction sectors.
Nakumatt Holdings Ltd. is the largest retail market player in east Africa with supermarkets in Kenya, Uganda and Rwanda.
** Special Webinar **
April 5, 2013 | Webinar
Join GBCHealth in an Expert Connections webinar and hear from the Global Fund's new Executive Director on how private sector companies can engage with the Global Fund. This webinar is the first in a three-part series on private sector partnerships with the Global Fund and will provide a valuable opportunity for companies to engage in a discussion with the Global Fund’s new ED about the organization’s private sector strategy in 2013. Learn how your company can make its biggest impact in the fight against AIDS, TB and malaria. Register now or learn more.
Ford Motor Co. and More Chief Executives join Pledge Opposing HIV Travel Bans
Mongolia has eliminated its travel restrictions against people living with HIV, leaving 44 countries that detain, deport or deny entry to people based solely on one’s HIV status.
GBCHealth, UNAIDS and Levi Strauss & Co. are leading an advocacy campaign to end HIV travel restrictions. Forty-eight chief executives from some of the world’s largest companies—including Johnson & Johnson, The Coca-Cola Company and the NBA—have signed a pledge calling for the end of these discriminatory measures.
Since our World AIDS Day campaign, executives from several companies have signed the pledge. They are Deutsche Post DHL; Ford Motor Company; Kiehl's USA; and Shanghai Desano Pharmaceuticals Investment Co., Ltd. Mongolia is the second country to lift its HIV travel restrictions since the International AIDS Conference in July.
Read UNAIDS story.
Read Huffington Post Op-ed by CEOs Chip Bergh of Levi Strauss and Kenneth Cole.
Learn more about the CEO pledge.
Latin America is one of the world’s booming economic regions and an area of growing interest to many GBCHealth members. To learn more about the ways in which business is engaging on health in the region, GBCHealth is partnering with the global management consulting firm Booz & Co. to survey companies active in the area. The resulting report will paint a vivid picture of the current state of private sector engagement on health and provide direction for further action. We invite companies with a presence in the Latin America region to take the survey. Click here for more information on how to participate.
GBCHealth is proud to announce that it will serve on the United Nations Population Fund’s (UNFPA) new private sector advisory panel to reduce maternal and newborn deaths in Kenya.
To address the problem of staggering rates of maternal mortality in the country, UNFPA’s Kenya Country Office has formed an advisory panel comprised of expert representatives from health, telecom, business and corporate citizenship sectors, among others. Neeta Bhandari, Regional Director of GBCHealth Kenya, will represent GBCHealth.
The panel aims to foster private-public sector partnerships, support capacity building, and mobilize resources and private sector assets to reduce maternal and newborn deaths. Read more.
February 28, 2013 | Johannesburg
Join our discussion on emerging health trends and how they will impact the decisions and actions of today’s Southern African business leaders at GBCHealth’s Members Meeting. GBCHealth will unveil our regional priorities for 2013, including agriculture and food security, maternal and child health, malaria, non-communicable diseases and health systems strengthening.
Special guests include Her Excellency Madam Dr. Christine Kaseba-Sata, First Lady of Zambia; Her Excellency Madam Bongi Zuma, First Lady of South Africa; Parks Tau, Executive Mayor of Johannesburg; Dr. Malick Diop, Deputy Mayor of Dakar, as well as representatives from the International Organization for Migration (IOM), South Africa Regional Network (SARN), UNAIDS, UNICEF and the World Health Organization (WHO).
GBCHealth members with significant operations in Africa are particularly encouraged to attend. Be part of the team that will drive health development in Southern Africa. Read more and reserve your space here.
Results from a large tuberculosis (TB) vaccine clinical trial in South Africa, sponsored by GBCHealth member Aeras, demonstrated that a new TB vaccine did not work in preventing the disease when tested in infants. The trial showed that the vaccine, which was developed as a booster to the current TB vaccine, was safe and induced a modest immune response but was not sufficient to protect the infants enrolled in the trial from disease.
Despite the results of the trial in 2,797 HIV-negative infants, Aeras and the researchers remain optimistic about the path forward for TB vaccine development, which includes a large pipeline of vaccine candidates.
The results come at a time when one-third of all people with active drug sensitive TB globally go undiagnosed and untreated, according to the World Health Organization. Additionally, TB has major economic consequences. The annual cost of controlling TB cases in South Africa, where the trial was held, is $300 million. Read more.
Medtronic, a GBCHealth member, recently launched a pilot employee volunteer program called Skills for Change in which experienced professionals apply their specialized expertise to health challenges in developing countries. The volunteers’ engagement also supports Medtronic's broader objectives to foster innovation and social responsibility across the corporation.
Read one Skills for Change participant’s blog post on traveling to Chennai, India to focus on gestational and type 2 diabetes.
January 26-27, 2013 | Beijing
GBCHealth’s VP and Beijing Regional Director, Michael Shiu, participated in the The Rockefeller Foundation’s recent Centennial Global Health Summit, hosted in conjunction with Peking Union Medical College. In keeping with its theme – “Dreaming the Future of Health for the Next 100 Years” – the event brought together over 200 leaders from government, academia, civil society and the private sector to discuss key global health challenges and opportunities in the coming century.
GBCHealth coordinated private sector engagement, ensuring that representatives from member companies had the chance to dialogue with some of the world’s foremost experts on global health. Participating member companies included BD (Becton, Dickinson and Company) Greater China; Coca-Cola Greater China; Hub One International; Inno Community Development Organization; Northeast Pharmaceutical Group Co., Ltd; Shanghai Desano Pharmaceuticals Investment Co., Ltd; and Standard Chartered Bank. Read more.
The Global Fund PSD has released its Winter 2012 newsletter, covering its recent work with the Global Fund to Fight AIDS, Tuberculosis and Malaria. In it you’ll find PSD news and updates as well as highlights from the September and November 2012 Global Fund Board Meetings. Recent developments include the appointment of a new Executive Director, Dr. Mark Dybul, and a new approach to grant-making. The newsletter also features Sumitomo Chemical's initiatives to prevent malaria in East Africa, and takes an in-depth look at Global Fund grants in Thailand. Read the newsletter here.
The current members of the PSD Advisory Group are: AbbVie, Abt Associates, Access Bank plc, Anglo American plc, Bayer, BD (Becton, Dickinson and Company), Chevron, Eli Lilly, Gilead Sciences Inc., HEINEKEN, Merck, Mylan, Novartis, (RED), SABMiller, Sanofi, Sumitomo Chemical, Vestergaard Frandsen Inc.
The United Nations and partners recently launched the MY World project to poll the world’s citizens on their top development priorities once the Millennium Development Goals expire in 2015.
Survey participants can choose development areas most important to them, such as environmental protection, healthcare, gender equality, education and political freedom.
The results will be shared with United Nations Secretary-General Ban Ki-moon’s High Level Panel on the Post-2015 Development Agenda this spring. Panel members will then make recommendations to Ban Ki-moon who will share them with the General Assembly in September.
Take the survey here.
The Health Enterprise Fund is launching a funding challenge to support innovative and replicable solutions that address critical health priorities in east Africa. The Fund, implemented by the USAID-sponsored Strengthening Health Outcomes through the Private Sector (SHOPS) project, provides grants coupled with technical assistance to health enterprises that operate in Kenya or Ethiopia. SHOPS is seeking applications from companies that address critical health issues in the areas of maternal and child health, family planning, reproductive health or HIV/AIDS in Kenya or Ethiopia.
Winners will receive grants ranging from $100,000 to $200,000 along with technical assistance. Applications are due March 8, 2013. Read more.
WHAT WE'RE READING
In his 2013 annual letter, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, expressed concern that altering the Millennium Development Goals (MDGs) after their 2015 expiration date could “sap momentum.” The MDGs have facilitated unprecedented collaboration and focused action, Gates said, but broadening a next set of goals could undermine global alignment.
“The success of the MDGs means that there is a lot of interest in expanding them to include a broader set of issues,” Gates wrote. “But many of the potential new goals don't have unanimous support, and adding many new goals, or goals that are not easily measurable, may sap momentum.”
The letter, which stressed how measurement is critical to improving global health, also lauded the MDGs for identifying the groups that needed to work together to forward the goals and for facilitating accountability and progress. Gates suggested that the U.N. “consider whether a different set of actors and a separate process might be best for those efforts” post-2015.
Johannesburg, South Africa
New York, New York